Prescription digital therapeutics: Applying Medicaid experience to value assessment and formulary management

Digital therapeutics (DTx) are a rapidly growing therapeutic category with more than 150 clinical trials evaluating US Food and Drug Administration–regulated DTx to develop additional evidence by the end of 2022. Investments in DTx development have doubled since 2019, reaching $14.7 billion in 2021....

Descripción completa

Detalles Bibliográficos
Autores principales: Salsabili, Mahsa, Tesell, Mark, Alcusky, Matthew, Greenwood, Bonnie C, Huang, Daniel, Lenz, Kimberly, Dave, Jatin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2023
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387922/
https://www.ncbi.nlm.nih.gov/pubmed/37276040
http://dx.doi.org/10.18553/jmcp.2023.29.6.685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387922/
https://www.ncbi.nlm.nih.gov/pubmed/37276040
http://dx.doi.org/10.18553/jmcp.2023.29.6.685

Ejemplares similares